Oakland, CALIFORNIA4 Active Studies

Lung Cancer Clinical Trials in Oakland, CALIFORNIA

Find 4 actively recruiting lung cancer clinical trials in Oakland, CALIFORNIA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
1,632
Enrolling

Recruiting Lung Cancer Studies in Oakland

RecruitingOakland, CALIFORNIANCT05061550

Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer

The study is intended to assess the safety and efficacy of perioperative treatment with Durvalumab in combination with Oleclumab, Monalizumab, or AZD0171 and platinum doublet chemotherapy (CTX); or Vo...

630 participants
AstraZeneca
View Study Details
RecruitingOakland, CALIFORNIANCT06305754

Sacituzumab Tirumotecan (MK-2870) Versus Pemetrexed and Carboplatin Combination Therapy in Participants With Epidermal Growth Factor (EGFR)-Mutated, Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC) Who Have Progressed on Prior EGFR Tyrosine Kinase Inhibitors (MK-2870-009)

The purpose of this study is to evaluate sacituzumab tirumotecan versus pemetrexed in combination with carboplatin for the treatment of epidermal growth factor receptor (EGFR)-mutated advanced non-squ...

520 participants
Merck Sharp & Dohme LLC
View Study Details
RecruitingOakland, CALIFORNIANCT06096844

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with mono...

304 participants
National Cancer Institute (NCI)
View Study Details
RecruitingOakland, CALIFORNIANCT05798663

Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC

This is a phase II trial of neoadjuvant and adjuvant atezolizumab with or without tiragolumab in conjunction with chemoradiotherapy for unresectable stage III NSCLC....

178 participants
Alliance Foundation Trials, LLC.
View Study Details

About Lung Cancer Clinical Trials in Oakland

Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.

There are currently 4 lung cancer clinical trials recruiting participants in Oakland, CALIFORNIA. These studies are seeking a combined 1,632 participants. Research is being sponsored by AstraZeneca, Merck Sharp & Dohme LLC, National Cancer Institute (NCI) and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lung Cancer Clinical Trials in Oakland — FAQ

Are there lung cancer clinical trials in Oakland?

Yes, there are 4 lung cancer clinical trials currently recruiting in Oakland, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Oakland?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Oakland research site will contact you about next steps.

Are clinical trials in Oakland free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Oakland studies also compensate for your time and travel.

What lung cancer treatments are being tested?

The 4 active trials in Oakland are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.

Data updated March 2, 2026 from ClinicalTrials.gov